Please assess the completion status of the following clinical trial:

Trial Title: Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with known or suspected prostate cancer who have been referred to the Department of Radiology at the University of Chicago Medical Center for a diagnostic MRI exam of the prostate, to be followed by an MRI-guided fusion biopsy of the prostate.~* Written informed consent.~Exclusion Criteria:~* Patients incapable of giving informed written consent;~* Patients who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher;~* Patients with psychiatric disorders that affect their ability to consent for themselves will be excluded and not the entire population of patients with psychiatric disorders.~* Prisoners;~* Minor children (under the age of 18 years old).

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Interventional Arm (Type: EXPERIMENTAL): Participants will undergo diagnostic MRI exam followed by clinical biopsies of suspected prostate cancer tumors.

Based on this trial design, predict the completion outcome and termination type (if applicable).